Effect of chronic treatment with Rosiglitazone on Leydig cell steroidogenesis in rats: <it>In vivo </it>and <it>ex vivo </it>studies

• Egile Nagusiak: Lima Maria C (Egilea), Galdino Suely L (Egilea), Vieira Juliany (Egilea), Peixoto Christina A (Egilea), Udrisar Daniel P (Egilea), Barros Cleiton D (Egilea), Saraiva Karina LA (Egilea), Couto Janaína A (Egilea), Pitta Ivan R (Egilea), Wanderley Maria I (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2010-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>The present study was designed to examine the effect of chronic treatment with rosiglitazone - thiazolidinedione used in the treatment of type 2 diabetes mellitus for its insulin sensitizing effects - on the Leydig cell steroidogenic...